Learning to share
By opening up its database of potential malaria drugs, GlaxoSmithKline has blazed a path that other pharmaceutical companies should follow. (Editorial)
Publication Date:
28/01/2010
463
7280
401
![]() |
By opening up its database of potential malaria drugs, GlaxoSmithKline has blazed a path that other pharmaceutical companies should follow. (Editorial)